P2Y 6 receptor contributes to neutrophil recruitment to inflamed intestinal mucosa by increasing CXC chemokine ligand 8 expression in an AP-1-dependent manner in epithelial cells

Inflammatory Bowel Diseases

Volumn 18, Issue 8, 2012, Pages 1456-1469

  Grbic, Djordje M ^a   Degagn, Émilie ^a   Larrive, Jean François ^a   Bilodeau, Maude S ^a   Vinette, Valrie ^a   Arguin, Guillaume ^a   Stankova, Jana ^a   Gendron, Fernand Pierre ^a  

^a UNIVERSITY OF SHERBROOKE   (Canada)

Author keywords

chemokines; epithelium; intestinal inflammation; neutrophils; nucleotides

Indexed keywords

INTERLEUKIN 8; PURINERGIC P2Y6 RECEPTOR; TRANSCRIPTION FACTOR AP 1; URIDINE DIPHOSPHATE; CXCL1 CHEMOKINE; CXCL1 PROTEIN, MOUSE; LUCIFERASE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PURINERGIC P2 RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHROMATIN IMMUNOPRECIPITATION; COLITIS; CONTROLLED STUDY; CYTOKINE RELEASE; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; INTESTINE EPITHELIUM CELL; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; ANIMAL; CELL CULTURE; ENTERITIS; EPITHELIUM CELL; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; GENETICS; IMMUNOLOGY; INFLAMMATION; INTESTINE MUCOSA; METABOLISM; PATHOLOGY; PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; BLOTTING, WESTERN; CELLS, CULTURED; CHEMOKINE CXCL1; CHROMATIN IMMUNOPRECIPITATION; EPITHELIAL CELLS; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; INFLAMMATION; INFLAMMATORY BOWEL DISEASES; INTERLEUKIN-8; INTESTINAL MUCOSA; LUCIFERASES; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NEUTROPHIL INFILTRATION; PHOSPHORYLATION; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, PURINERGIC P2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR AP-1;

EID: 84863983190     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.21931     Document Type: Article

References (61)

1. Arseneau KO, Tamagawa H, Pizarro TT, et al. Innate and adaptive immune responses related to IBD pathogenesis. Curr Gastroenterol Rep. 2007; 9: 508-512.
2. Mantovani A, Cassatella MA, Costantini C, et al. Neutrophils in the activation and regulation of innate and adaptive immunity. Nat Rev Immunol. 2011; 11: 519-531.
3. Chin AC, Parkos CA,. Neutrophil transepithelial migration and epithelial barrier function in IBD: potential targets for inhibiting neutrophil trafficking. Ann N Y Acad Sci. 2006; 1072: 276-287.
4. McCormick BA, Hofman PM, Kim J, et al. Surface attachment of Salmonella typhimurium to intestinal epithelia imprints the subepithelial matrix with gradients chemotactic for neutrophils. J Cell Biol. 1995; 131: 1599-1608.
5. Carrigan SO, Pink DB, Stadnyk AW,. Neutrophil transepithelial migration in response to the chemoattractant fMLP but not C5a is phospholipase D-dependent and related to the use of CD11b/CD18. J Leukoc Biol. 2007; 82: 1575-1584.
6. Reaves TA, Colgan SP, Selvaraj P, et al. Neutrophil transepithelial migration: regulation at the apical epithelial surface by Fc-mediated events. Am J Physiol Gastrointest Liver Physiol. 2001; 280: G746-754.
7. Larmonier CB, Midura-Kiela MT, Ramalingam R, et al. Modulation of neutrophil motility by curcumin: implications for inflammatory bowel disease. Inflamm Bowel Dis. 2011; 17: 503-515.
8. Bours MJ, Swennen EL, Di Virgilio F, et al. Adenosine 5'-triphosphate and adenosine as endogenous signaling molecules in immunity and inflammation. Pharmacol Ther. 2006; 112: 358-404.
9. Degagne E, Grbic DM, Dupuis AA, et al. P2Y2 receptor transcription is increased by NF-kappa B and stimulates cyclooxygenase-2 expression and PGE2 released by intestinal epithelial cells. J Immunol. 2009; 183: 4521-4529.
10. Grbic DM, Degagne E, Langlois C, et al. Intestinal inflammation increases the expression of the P2Y6 receptor on epithelial cells and the release of CXC chemokine ligand 8 by UDP. J Immunol. 2008; 180: 2659-2668.
11. Langlois C, Gendron FP,. Promoting Mf transepithelial migration by stimulating the epithelial cell P2Y(2) receptor. Eur J Immunol. 2009; 39: 2895-2905.
12. Warny M, Aboudola S, Robson SC, et al. P2Y(6) nucleotide receptor mediates monocyte interleukin-8 production in response to UDP or lipopolysaccharide. J Biol Chem. 2001; 276: 26051-26056.
13. Korcok J, Raimundo LN, Du X, et al. P2Y6 nucleotide receptors activate NF-kappaB and increase survival of osteoclasts. J Biol Chem. 2005; 280: 16909-16915.
14. Lazarowski ER, Boucher RC, Harden TK,. Mechanisms of release of nucleotides and integration of their action as P2X- and P2Y-receptor activating molecules. Mol Pharmacol. 2003; 64: 785-795.
15. Boeynaems JM, Communi D, Gonzalez NS, et al. Overview of the P2 receptors. Semin Thromb Hemost. 2005; 31: 139-149.
16. Abbracchio MP, Burnstock G, Boeynaems JM, et al. International Union of Pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy. Pharmacol Rev. 2006; 58: 281-341.
17. Dubyak GR, el-Moatassim C,. Signal transduction via P2-purinergic receptors for extracellular ATP and other nucleotides. Am J Physiol. 1993; 265: C577-606.
18. Somers GR, Hammet FM, Trute L, et al. Expression of the P2Y6 purinergic receptor in human T cells infiltrating inflammatory bowel disease. Lab Invest. 1998; 78: 1375-1383.
19. Cox MA, Gomes B, Palmer K, et al. The pyrimidinergic P2Y6 receptor mediates a novel release of proinflammatory cytokines and chemokines in monocytic cells stimulated with UDP. Biochem Biophys Res Commun. 2005; 330: 467-473.
20. Relvas LJ, Bouffioux C, Marcet B, et al. Extracellular nucleotides and interleukin-8 production by ARPE cells: potential role of danger signals in blood-retinal barrier activation. Invest Ophthalmol Vis Sci. 2009; 50: 1241-1246.
21. Ebert EC,. Human intestinal intraepithelial lymphocytes have potent chemotactic activity. Gastroenterology. 1995; 109: 1154-1159.
22. Ebert EC, Panja A, Praveen R,. Human intestinal intraepithelial lymphocytes and epithelial cells coinduce interleukin-8 production through the CD2-CD58 interaction. Am J Physiol Gastrointest Liver Physiol. 2009; 296: G671-677.
23. Sallusto F, Schaerli P, Loetscher P, et al. Rapid and coordinated switch in chemokine receptor expression during dendritic cell maturation. Eur J Immunol. 1998; 28: 2760-2769.
24. Chin AC, Lee WY, Nusrat A, et al. Neutrophil-mediated activation of epithelial protease-activated receptors-1 and -2 regulates barrier function and transepithelial migration. J Immunol. 2008; 181: 5702-5710.
25. Nusrat A, Parkos CA, Liang TW, et al. Neutrophil migration across model intestinal epithelia: monolayer disruption and subsequent events in epithelial repair. Gastroenterology. 1997; 113: 1489-1500.
26. Brasier AR, Jamaluddin M, Casola A, et al. A promoter recruitment mechanism for tumor necrosis factor-alpha-induced interleukin-8 transcription in type II pulmonary epithelial cells. Dependence on nuclear abundance of Rel A, NF-kappaB1, and c-Rel transcription factors. J Biol Chem. 1998; 273: 3551-3561.
27. Hoffmann E, Dittrich-Breiholz O, Holtmann H, et al. Multiple control of interleukin-8 gene expression. J Leukoc Biol. 2002; 72: 847-855.
28. Roger T, Out T, Mukaida N, et al. Enhanced AP-1 and NF-kappaB activities and stability of interleukin 8 (IL-8) transcripts are implicated in IL-8 mRNA superinduction in lung epithelial H292 cells. Biochem J. 1998; 330 (Pt 1): 429-435.
29. Karin M,. The regulation of AP-1 activity by mitogen-activated protein kinases. J Biol Chem. 1995; 270: 16483-16486.
30. Moriyama I, Ishihara S, Rumi MA, et al. Decoy oligodeoxynucleotide targeting activator protein-1 (AP-1) attenuates intestinal inflammation in murine experimental colitis. Lab Invest. 2008; 88: 652-663.
31. Beijer S, Hupperets PS, van den Borne BE, et al. Randomized clinical trial on the effects of adenosine 5'-triphosphate infusions on quality of life, functional status, and fatigue in preterminal cancer patients. J Pain Symptom Manage. 2010; 40: 520-530.
32. Agteresch HJ, Dagnelie PC, van der Gaast A, et al. Randomized clinical trial of adenosine 5'-triphosphate in patients with advanced non-small-cell lung cancer. J Natl Cancer Inst. 2000; 92: 321-328.
33. Haskell CM, Mendoza E, Pisters KM, et al. Phase II study of intravenous adenosine 5'-triphosphate in patients with previously untreated stage IIIB and stage IV non-small cell lung cancer. Invest New Drugs. 1998; 16: 81-85.
34. Weigmann B, Tubbe I, Seidel D, et al. Isolation and subsequent analysis of murine lamina propria mononuclear cells from colonic tissue. Nat Protoc. 2007; 2: 2307-2311.
35. Akhtar M, Watson JL, Nazli A, et al. Bacterial DNA evokes epithelial IL-8 production by a MAPK-dependent, NF-kappaB-independent pathway. FASEB J. 2003; 17: 1319-1321.
36. Lee JY, Park HR, Oh YK, et al. Effects of transcription factor activator protein-1 on interleukin-8 expression and enteritis in response to Clostridium difficile toxin A. J Mol Med. 2007; 85: 1393-1404.
37. Gomard T, Jariel-Encontre I, Basbous J, et al. Fos family protein degradation by the proteasome. Biochem Soc Trans. 2008; 36: 858-863.
38. Bozic CR, Gerard NP, von Uexkull-Guldenband C, et al. The murine interleukin 8 type B receptor homologue and its ligands. Expression and biological characterization. J Biol Chem. 1994; 269: 29355-29358.
39. Christ AD, Blumberg RS,. The intestinal epithelial cell: immunological aspects. Springer Semin Immunopathol. 1997; 18: 449-461.
40. Matsuda R, Koide T, Tokoro C, et al. Quantitative cytokine mRNA expression profiles in the colonic mucosa of patients with steroid naive ulcerative colitis during active and quiescent disease. Inflamm Bowel Dis. 2009; 15: 328-334.
41. Agius LM,. A primary dysregulation in the immunoregulatory role of the intestinal mucosal epithelial cell in inflammatory bowel disease pathogenesis? Biology of inflammatory response as tissue pattern entities in Crohn's versus ulcerative colitis. J Theor Biol. 2004; 227: 219-228.
42. Fiocchi C,. Intestinal inflammation: a complex interplay of immune and nonimmune cell interactions. Am J Physiol. 1997; 273: G769-775.
43. McKay DM,. Good bug, bad bug: in the case of enteric inflammatory disease does the epithelium decide? Mem Inst Oswaldo Cruz. 2005; 100 (Suppl 1): 205-210.
44. Darsigny M, Babeu JP, Dupuis AA, et al. Loss of hepatocyte-nuclear- factor-4alpha affects colonic ion transport and causes chronic inflammation resembling inflammatory bowel disease in mice. PLoS One. 2009; 4: e7609.
45. Mendoza JL, Abreu MT,. Biological markers in inflammatory bowel disease: practical consideration for clinicians. Gastroenterol Clin Biol. 2009; 33 (Suppl 3): S158-173.
46. Shi D, Das J, Das G,. Inflammatory bowel disease requires the interplay between innate and adaptive immune signals. Cell Res. 2006; 16: 70-74.
47. Niess JH,. Role of mucosal dendritic cells in inflammatory bowel disease. World J Gastroenterol. 2008; 14: 5138-5148.
48. Nishida M, Sato Y, Uemura A, et al. P2Y6 receptor-Galpha12/13 signalling in cardiomyocytes triggers pressure overload-induced cardiac fibrosis. EMBO J. 2008; 27: 3104-3115.
49. Rieder F, Fiocchi C,. Intestinal fibrosis in IBDa dynamic, multifactorial process. Nat Rev Gastroenterol Hepatol. 2009; 6: 228-235.
50. Casola A, Garofalo RP, Crawford SE, et al. Interleukin-8 gene regulation in intestinal epithelial cells infected with rotavirus: role of viral-induced IkappaB kinase activation. Virology. 2002; 298: 8-19.
51. Mamedova LK, Wang R, Besada P, et al. Attenuation of apoptosis in vitro and ischemia/reperfusion injury in vivo in mouse skeletal muscle by P2Y6 receptor activation. Pharmacol Res. 2008; 58: 232-239.
52. Kim SG, Gao ZG, Soltysiak KA, et al. P2Y6 nucleotide receptor activates PKC to protect 1321N1 astrocytoma cells against tumor necrosis factor-induced apoptosis. Cell Mol Neurobiol. 2003; 23: 401-418.
53. Mukaida N, Mahe Y, Matsushima K,. Cooperative interaction of nuclear factor-kappa B- and cis-regulatory enhancer binding protein-like factor binding elements in activating the interleukin-8 gene by pro-inflammatory cytokines. J Biol Chem. 1990; 265: 21128-21133.
54. Jiang Y, Borrelli L, Bacskai BJ, et al. P2Y6 receptors require an intact cysteinyl leukotriene synthetic and signaling system to induce survival and activation of mast cells. J Immunol. 2009; 182: 1129-1137.
55. Muscella A, Greco S, Elia MG, et al. Differential signalling of purinoceptors in HeLa cells through the extracellular signal-regulated kinase and protein kinase C pathways. J Cell Physiol. 2004; 200: 428-439.
56. Wong AM, Chow AW, Au SC, et al. Apical versus basolateral P2Y(6) receptor-mediated Cl(-) secretion in immortalized bronchial epithelia. Am J Respir Cell Mol Biol. 2009; 40: 733-745.
57. Smith FD, Langeberg LK, Scott JD,. Plugging PKA into ERK scaffolds. Cell Cycle. 2011; 10: 731-732.
58. Frodin M, Gammeltoft S,. Role and regulation of 90 kDa ribosomal S6 kinase (RSK) in signal transduction. Mol Cell Endocrinol. 1999; 151: 65-77.
59. Schinelli S, Zanassi P, Paolillo M, et al. Stimulation of endothelin B receptors in astrocytes induces cAMP response element-binding protein phosphorylation and c-fos expression via multiple mitogen-activated protein kinase signaling pathways. J Neurosci. 2001; 21: 8842-8853.
60. Dunn C, Wiltshire C, MacLaren A, et al. Molecular mechanism and biological functions of c-Jun N-terminal kinase signalling via the c-Jun transcription factor. Cell Signal. 2002; 14: 585-593.
61. Chen LC, Chen BK, Chang WC,. Activating protein 1-mediated cyclooxygenase-2 expression is independent of N-terminal phosphorylation of c-Jun. Mol Pharmacol. 2005; 67: 2057-2069.